Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies

Elise Grignard; Robert  Taylor; Mark  McAllister; Karl Box; Nikoletta Fotaki

doi:10.1016/j.ejps.2016.12.004

Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies

Elise Grignard, Robert Taylor, Mark McAllister, Karl Box, Nikoletta Fotaki

Department of Pharmacy & Pharmacology

Research output: Contribution to journal › Article › peer-review

15 Citations (SciVal)

365 Downloads (Pure)

Original language	English
Pages (from-to)	193-201
Journal	European Journal of Pharmaceutical Sciences
Volume	99
Early online date	7 Dec 2016
DOIs	https://doi.org/10.1016/j.ejps.2016.12.004
Publication status	Published - 1 Mar 2017

Access to Document

10.1016/j.ejps.2016.12.004

Preclinical Biorelevant EJPS Dr N FotakiAccepted author manuscript, 589 KBLicence: CC BY-NC-ND

Cite this

@article{e2bdbebf36834fbdba80dc1882ed595f,

title = "Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies",

author = "Elise Grignard and Robert Taylor and Mark McAllister and Karl Box and Nikoletta Fotaki",

year = "2017",

month = mar,

day = "1",

doi = "10.1016/j.ejps.2016.12.004",

language = "English",

volume = "99",

pages = "193--201",

journal = "European Journal of Pharmaceutical Sciences",

issn = "0928-0987",

publisher = "Elsevier",

}

TY - JOUR

T1 - Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies

AU - Grignard, Elise

AU - Taylor, Robert

AU - McAllister, Mark

AU - Box, Karl

AU - Fotaki, Nikoletta

PY - 2017/3/1

Y1 - 2017/3/1

UR - https://doi.org/10.1016/j.ejps.2016.12.004

U2 - 10.1016/j.ejps.2016.12.004

DO - 10.1016/j.ejps.2016.12.004

M3 - Article

VL - 99

SP - 193

EP - 201

JO - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

ER -

Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies

Access to Document

Other files and links

Cite this